Management of Patients With EGFR Exon 20-Mutant Advanced Non-Small Cell Lung Cancer

J Clin Oncol. 2025 May;43(13):1527-1533. doi: 10.1200/JCO-24-02624. Epub 2025 Mar 7.

Abstract

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • ErbB Receptors* / antagonists & inhibitors
  • ErbB Receptors* / genetics
  • Exons
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / therapy
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • EGFR protein, human
  • ErbB Receptors
  • Protein Kinase Inhibitors